Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial
Xinhui Ran, ANTHONY C. KEECH, Marc S. Sabatine, Narimon Honarpour et al.
Citations
7 citations
Journal
Circulation
Topics
Lipoproteins and Cardiovascular Health
Field-Weighted Citation Impact (FWCI)
14.04
article
Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial
Xinhui Ran, ANTHONY C. KEECH, Marc S. Sabatine, Narimon Honarpour, Huei Wang, Robert P. Giugliano, Brittany Weber, Peter S. Sever, André Zimerman, Sabina A. Murphy, Ana Laura Fischer Kunzler
article en
7 citations
Abstract
No abstract available for this paper.
Publication Tag
CirculationVol. 151(20)
Institutions
Brigham and Women's Hospital (US), The University of Sydney (AU), Center for Global Development (US), Amgen (United States) (US), Harvard University (US), Hospital Moinhos de Vento (BR), Lung Institute (US), Thrombolysis in Myocardial Infarction Study Group (US), National Health and Medical Research Council (AU)